BioCentury
ARTICLE | Company News

Pfizer sales and marketing update

September 5, 2016 7:00 AM UTC

The U.K.’s NICE issued final guidance recommending the use of Bosulif bosutinib from Pfizer to treat chronic, accelerated and blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous le...